Alzheimer Disease Clinical Trials

135 studies are recruiting for alzheimer disease in the United States right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

By city

Studies, page 6

1. Longitudinal Cognitive Assessment by BoCA

   The Boston Cognitive Assessment (BoCA) is a self-administered online test intended for longitudinal cognitive monitoring. BoCA uses random not-repeating tasks to minimize learning effects. BoCA was developed to evaluate the effects of treatment in longitudinal clinical trials and available gratis t…

   Stage

   Not phased

   Ages

   50 and older

   Site

   Andrey Vyshedskiy, Miami, Florida

   Run by

   Alzheimer's Light LLC

   See if you can join NCT04114994 on ClinicalTrials.gov

2. Paper-Based and Smartphone-Based Memory Supports

   Alzheimer's disease and related dementias lead to marked declines in daily functioning, independence, and quality of life. One of the earliest cognitive changes in these conditions is impairment in prospective memory, or the ability to remember future intentions such as taking medications at a give…

   Stage

   Not phased

   Ages

   50 and older

   Site

   UT Health Austin Comprehensive Memory Center, Austin, Texas

   Locations

   3 in total

   Run by

   Baylor University

   See if you can join NCT06444841 on ClinicalTrials.gov

3. Sleep Healthy Using the Internet Mitigating Insomnia to Address Neurocognitive Difficulties (SHUTi MIND)

   This randomized controlled trial will evaluate the impact of an Internet-delivered cognitive behavioral therapy for insomnia (CBT-I) intervention on sleep and the extent to which it contributes to cognitive health in individuals with mild cognitive impairment. Participants with insomnia who meet th…

   Stage

   Phase 2

   Ages

   65 and older

   Site

   University of Virginia, Charlottesville, Virginia

   Run by

   University of Virginia

   See if you can join NCT05565833 on ClinicalTrials.gov

4. Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase

   This study seeks to improve clinical outcomes for an important, growing, and vulnerable population-nursing home residents with Alzheimer's disease or related dementias-by testing an evidence-based intervention to improve these residents' sleep. It will also examine the implementation and sustainmen…

   Stage

   Not phased

   Ages

   50 and older

   Site

   Vivage/Beecan Corporation, Lakewood, Colorado

   Locations

   3 in total

   Run by

   University of Alabama, Tuscaloosa

   See if you can join NCT05820919 on ClinicalTrials.gov

5. Alzheimer's National Registry for Treatment and Diagnostics(ALZ-NET)

   The Alzheimer's Network for Treatment and Diagnostics (ALZ-NET) will collect longitudinal clinical and safety data for enrolled patients being evaluated for or treated with novel FDA-approved Alzheimer's disease (AD) therapies. ALZ-NET is a longitudinal registry with an expandable platform, designe…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Full List of Active Sites, Chicago, Illinois

   Run by

   Alzheimer's Disease and Related Disorders Association, Inc

   See if you can join NCT06170268 on ClinicalTrials.gov

6. Triage Survey for Neurology Research Eligibility

   TRIAGE-Neuro is a survey study designed to assess potential participants' eligibility to screen for industry-sponsored neurology clinical trials.

   Stage

   Not phased

   Ages

   18 and older

   Site

   Adams Clinical, Watertown, Massachusetts

   Locations

   3 in total

   Run by

   Adams Clinical

   See if you can join NCT06104852 on ClinicalTrials.gov

7. Gamma-Music Based Intervention for Mild Alzheimer's Disease

   The study will test and refine a novel brain-stimulation tool using gamma-frequency lights coupled with self-selected music for a gamma-music-based intervention for participants with mild Alzheimer's Disease. Results will yield a gamma-stimulation protocol that reliably influences brain activity (A…

   Stage

   Not phased

   Ages

   50 to 95

   Site

   Northeastern University, Boston, Massachusetts

   Run by

   Northeastern University

   See if you can join NCT05984524 on ClinicalTrials.gov

8. Effects of THC-Free CBD Oil on Agitation in Patients With Alzheimer's Disease

   This is a randomized, double-blinded, placebo-controlled, crossover trial that aims to 1) determine the efficacy of THC-free cannabidiol (CBD oil) in reducing the severity of agitation among participants and 2) determine whether THC-free CBD oil can reduce the burden on caregivers and increase the …

   Stage

   Phase 2

   Ages

   50 to 90

   Site

   Eastern Virginia Medical School, Norfolk, Virginia

   Run by

   Eastern Virginia Medical School

   See if you can join NCT04436081 on ClinicalTrials.gov

9. Nighttime Agitation and Restless Legs Syndrome in People With Alzheimer's Disease

   Nighttime agitation in persons with Alzheimer's disease causes patient suffering, distresses caregivers, and often results in prescriptions for harmful antipsychotics. Effective treatments are lacking because of limited knowledge of the etiology of nighttime agitation. The investigators propose a c…

   Stage

   Phase 4

   Ages

   55 and older

   Site

   The University of Texas at Austin, Austin, Texas

   Run by

   University of Texas at Austin

   See if you can join NCT03082755 on ClinicalTrials.gov

10. DC Longitudinal Study on Aging and Specimen Bank

    The Georgetown University Memory Disorders Program, part of the Department of Neurology, is conducting pilot studies of the feasibility of various diagnostic tests for Alzheimer's disease, mild cognitive impairment and other neurodegenerative diseases. Further, this study is assessing longitudinal …

    Stage

    Not phased

    Ages

    45 and older

    Site

    Georgetown University Memory Disorders Program, Washington D.C., District of Columbia

    Run by

    Georgetown University

    See if you can join NCT03702907 on ClinicalTrials.gov